More importantly, in Supplementary Fig. 1, it was found that the expression of M2-type macrophage marker (CD206) was significantly higher and the expression of M1-type macrophage marker (iNOS) was significantly lower in tumor tissues of PTX-resistant patients than those of PTX-sensitive patients. Here, MRC1 is linked to neoplasm.